Intestinal ultrasonography (IUS) is an emerging, noninvasive, highly accessible and low-cost cross-sectional imaging modality for inflammatory bowel disease. This Comment summarizes how IUS in a point-of-care setting enables close patient monitoring.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Maaser, C. et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn’s and Colitis 13, 144–164K (2019).
Kucharzik, T. et al. Use of intestinal ultrasound to monitor Crohn’s disease activity. Clinical Gastroenterology and Hepatology 15, 535–542. e532 (2017).
Maaser, C. et al. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study. Gut 69, 1629–1636 (2020).
Taylor, S. A. et al. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease (METRIC): a multicentre trial. The lancet Gastroenterology & hepatology 3, 548–558 (2018).
Panes, J. et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. 34, 125–145 (2011).
Smith, R. L. et al. Systematic Review: Clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis. J. Crohns Colitis 14, 465–479 (2020).
Novak, K. L. et al. Expert consensus on optimal acquisition and development of the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS): a reliability and inter-rater variability study on intestinal ultrasonography in Crohn’s Disease. Journal of Crohn’s and Colitis (2020).
Kucharzik, T. W. R. et al. Intestinal ultrasound response and transmural healing after ustekinumab induction in crohn’s disease: week 16 interim analysis of the stardust trial substudy. Gastroenterology 158, S61 (2020).
Yung, D. E. et al. Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn’s Disease: Systematic Review and Meta-Analysis. Inflamm Bowel Dis 24, 93–100 (2017).
Goodsall, T. M. et al. Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease. J Crohns Colitis https://doi.org/10.1093/ecco-jcc/jjaa129 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
F.A.E.d-.V. reports honoraria fees from AbbVie and Janssen. B.V. reports financial support for research from Pfizer, lecture fees from Abbvie, Ferring, Janssen, R Biopharm and Takeda Pharmaceuticals, and consultancy fees from Guidepont, Janssen and Sandoz. C.M. reports lecture fees and/or consultancy fees from Abbvie, Biogen, Celgene, Dr. Falk Pharma Ferring, Galapagos, Gilead, Janssen, MSD Sharp & Dome, Pfizer, Roche and Takeda Pharmaceuticals. K.B.G. has received consultancy fees and/or speaker’s honoraria from AbbVie, Boehringer Ingelheim, Celltrion, Ferring, Gilead, Immunic Therapeutics, Janssen, Pfizer, Samsung Bioepis, Sandoz, Takeda and Tillotts.
Additional information
Related links
International Bowel Ultrasound Group: https://www.ibus-group.org/index.php/en/
U.S. National Library of Medicine Clinical Trials.gov: https://clinicaltrials.gov/
Supplementary information
41575_2021_418_MOESM2_ESM.wmv
Supplementary Video 1 | Supplementary Figure 1a at baseline. Intestinal ultrasonography video of the sigmoid colon of a patient with ulcerative colitis at baseline.
41575_2021_418_MOESM3_ESM.wmv
Supplementary Video 2 | Supplementary Figure 1a at 6 weeks. Intestinal ultrasonography video of the sigmoid colon of a patient with ulcerative colitis at 6 weeks after starting infliximab in combination with thiopurine.
41575_2021_418_MOESM4_ESM.wmv
Supplementary Video 3 | Supplementary Figure 1a at 20 weeks. Intestinal ultrasonography video of the sigmoid colon of a patient with ulcerative colitis at 20 weeks after starting infliximab in combination with thiopurine.
41575_2021_418_MOESM5_ESM.wmv
Supplementary Video 4 | Supplementary Figure 1b at baseline. Intestinal ultrasonography video of the terminal ileum of a patient with Crohn’s disease at baseline.
41575_2021_418_MOESM6_ESM.wmv
Supplementary Video 5 | Supplementary Figure 1b at 12 weeks. Intestinal ultrasonography video of the terminal ileum of a patient with Crohn’s disease at 12 weeks after starting adalimumab monotherapy.
41575_2021_418_MOESM7_ESM.wmv
Supplementary Video 6 | Supplementary Figure 1b at 20 weeks. Intestinal ultrasonography video of the terminal ileum of a patient with Crohn’s disease at 20 weeks after starting adalimumab monotherapy.
Rights and permissions
About this article
Cite this article
de Voogd, F.A.E., Verstockt, B., Maaser, C. et al. Point-of-care intestinal ultrasonography in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 18, 209–210 (2021). https://doi.org/10.1038/s41575-021-00418-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-021-00418-4
